Results 321 to 330 of about 122,145 (339)

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease

International Journal of COPD, 2023
Jun Chen
exaly  

[Glucagon-like peptide-1 receptor agonists].

Nihon rinsho. Japanese journal of clinical medicine, 2012
Takeshi, Kurose, Yutaka, Seino
openaire   +1 more source

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

Circulation, 2019
Stephen Wiviott, Itamar Raz, Marc P Bonaca   +2 more
exaly  

Glucagon-Like Peptide 1 Receptor Agonist Use Before Surgery

JAMA Surgery
Philip M, Jones, Ion A, Hobai
openaire   +2 more sources

Chapter 13: Glucagon-Like Peptide-1 Receptor Agonists

2022
openaire   +1 more source

Glucagon-like peptide-1 receptor agonists and aspiration risk

BMJ
Daniel I, McIsaac, Gregory L, Bryson
openaire   +2 more sources

Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

Lancet, The, 2014
Bernard Zinman Cm, Ravi Retnakaran, Caroline K Kramer   +2 more
exaly  

Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist?

Lancet, The, 2019
Jens J Holst Dmsci
exaly  

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis

Lancet Diabetes and Endocrinology,the, 2018
Juliana Chung-ngor Chan, Aldo P Maggioni, Bernard Zinman Cm   +2 more
exaly  

Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis

New England Journal of Medicine
openaire   +2 more sources